BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee W, Il An G, Park H, Sarkar S, Ha YS, Huynh PT, Bhise A, Bhatt N, Ahn H, Pandya DN, Kim JY, Kim S, Jun E, Kim SC, Lee KC, Yoo J. Imaging Strategy that Achieves Ultrahigh Contrast by Utilizing Differential Esterase Activity in Organs: Application in Early Detection of Pancreatic Cancer. ACS Nano 2021. [PMID: 34405675 DOI: 10.1021/acsnano.1c05165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lai Y, Zhang T, Huang L, Li W, Lin W. Monitoring cell viability in N-nitrosodiethylamine induced acute hepatitis and detection of hydrazine in solution and gas phase with Dual-function fluorescent probes. Journal of Hazardous Materials 2023;443:130207. [DOI: 10.1016/j.jhazmat.2022.130207] [Reference Citation Analysis]
2 Shan H, Sun X, Liu X, Sun Q, He Y, Chen Z, Lin Q, Jiang Z, Chen X, Chen Z, Zhao S. One‐Step Formation of Targeted Liposomes in a Versatile Microfluidic Mixing Device. Small 2022. [DOI: 10.1002/smll.202205498] [Reference Citation Analysis]
3 Rimal R, Desai P, Daware R, Hosseinnejad A, Prakash J, Lammers T, Singh S. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting. Adv Drug Deliv Rev 2022;189:114504. [PMID: 35998825 DOI: 10.1016/j.addr.2022.114504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Poletto G, Evangelista L, Venturini F, Gramegna F, Seno F, Moro S, Vettor R, Realdon N, Cecchin D. Nanoparticles and Radioisotopes: A Long Story in a Nutshell. Pharmaceutics 2022;14:2024. [DOI: 10.3390/pharmaceutics14102024] [Reference Citation Analysis]
5 Lindsley CW, Müller CE, Bongarzone S. Diagnostic and Therapeutic Radiopharmaceuticals. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00173] [Reference Citation Analysis]
6 Lindsley CW, Müller CE, Bongarzone S. Diagnostic and Therapeutic Radiopharmaceuticals. J Med Chem . [DOI: 10.1021/acs.jmedchem.2c01403] [Reference Citation Analysis]
7 He H, Zhang X, Du L, Ye M, Lu Y, Xue J, Wu J, Shuai X. Molecular imaging nanoprobes for theranostic applications. Adv Drug Deliv Rev 2022;186:114320. [PMID: 35526664 DOI: 10.1016/j.addr.2022.114320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Desai P, Rimal R, Sahnoun SEM, Mottaghy FM, Möller M, Morgenroth A, Singh S. Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers. Small. [DOI: 10.1002/smll.202200673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Llop J, Lammers T. Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics. ACS Nano 2021. [PMID: 34748314 DOI: 10.1021/acsnano.1c09139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]